Suparna Mishra Sarkar, Ph.D.

Dr. Mishra has over 25 years of experience in biomedical research including her most recent 10 years in Quality. As Armata’s Vice President of Quality, Dr. Mishra is responsible for ensuring compliance with cGMP and GLP standards in the production and testing of investigational products, as well as ensuring GCP compliance in the conduct of clinical trials. Dr. Mishra joined Armata in 2020 and successfully built a Quality Assurance Department, implementing phase-appropriate quality systems for the conduct of clinical trials. Dr. Mishra began her career in Quality at Calimmune Inc., a company co-founded by Nobel Laureate, David Baltimore, and later acquired by CSL Behring. At Calimmune, she developed and upgraded the quality management system, including the implementation of an electronic quality management system. She has also worked at HemaCare, a Charles River Company, where she had an integral role in maintaining quality and regulatory compliance in the manufacture of donor-derived blood products. She earned a Ph.D. in Molecular Pathology from the Keck School of Medicine, University of Southern California. While working as a postdoctoral scholar at the Children’s Hospital of Los Angeles, she received the California Institute of Regenerative Medicine grant award (CIRM) and the A.P. Giannini Medical Fellowship award for her translational research work on Cystic Fibrosis. As a Researcher at the University of California in Los Angeles, Dr. Mishra was responsible for the manufacture of autologous gene therapy products for multiple Phase 1/2 clinical trials, as well as management responsibilities for the cGMP facility and the clinical laboratories.